Harness Dickey
  • People
  • Global IP Services
    • Practice Areas
    • Industries
    • Case Studies
  • Blog
  • News & Awards
  • About Us
    • Careers
    • Offices
  • IP Atlas
  • Contact Us
  • Client Login

Blog

Subscribe to our Blogs

  • Subscribe to our Blogs

Our business model is to cultivate lawyers who know all there is to know about intellectual property, whether it be special requirements under the America Invents Act (AIA), patenting chemical compositions and pharmaceuticals, current developments in software patenting, or combating “bad patents” in federal court litigation.  Lawyers from our various practice groups enjoy sharing their views in our blogs. Please join our audience and help us enrich the discussion. We welcome your participation and insight.

  • FDA Guidance & Updates

      ALL CATEGORIES

      • Biologics & Biosimilars
        • Antitrust Issues
        • Competitor Dynamics
        • FDA Guidance & Updates
        • Interchangeability
      • BioPharma
      • Chemistry & Nanotechnology
      • IP Management
      • IPR-PGR
      • Litigation
      • Patent Prosecution
      • quIPs
      • Trademarks
  • All Years
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
  • Authors
    • John H. Ambrose, Jr.John H. Ambrose, Jr. 2
    • Jewell N. BriggsJewell N. Briggs 8
    • Elizabeth K. BrockElizabeth K. Brock 7
    • Christopher M. CaubleChristopher M. Cauble 1
    • Matthew L. CutlerMatthew L. Cutler 15
    • Donald J. DaleyDonald J. Daley 1
    • Darin W. DeaverDarin W. Deaver 1
    • Nicholas S. DrysdaleNicholas S. Drysdale 7
    • Monte L. FalcoffMonte L. Falcoff 1
    • Glenn E. ForbisGlenn E. Forbis 11
    • Michael GambleMichael Gamble 1
    • Jason A. HeistJason A. Heist 1
    • Hemant M. KeskarHemant M. Keskar 4
    • Sung Pil KimSung Pil Kim 1
    • Elisabeth A. KoralElisabeth A. Koral 10
    • Damian H. Kotsis, Ph.D.Damian H. Kotsis, Ph.D. 4
    • Kisuk LeeKisuk Lee 1
    • Robert J. LenihanRobert J. Lenihan 1
    • Chris K. MillerChris K. Miller 1
    • Michael R. NyeMichael R. Nye 1
    • Joshua A. PartingtonJoshua A. Partington 4
    • Leanne M. RakersLeanne M. Rakers 15
    • Douglas A. RobinsonDouglas A. Robinson 15
    • Joel R. SamuelsJoel R. Samuels 14
    • Jeffrey L. SnyderJeffrey L. Snyder 1
    • David J. SteinDavid J. Stein 1
    • David L. SuterDavid L. Suter 2
    • Michael L. TaylorMichael L. Taylor 1
    • Jennifer R. TurchynJennifer R. Turchyn 4
    • Michael VarcoMichael Varco 3
    • Joseph E. Walsh, Jr.Joseph E. Walsh, Jr. 1
    • Andrew M. WaxmanAndrew M. Waxman 2
    • Bryan K. WheelockBryan K. Wheelock 15
    • Jennifer M. Woodside WojtalaJennifer M. Woodside Wojtala 13
    • Scott E. YackeyScott E. Yackey 1
    • Paul E. Zarek, Ph.D.Paul E. Zarek, Ph.D. 3

  • September 12, 2019

    The Emerging Battleground of Machine Learning Patent Protection

    More

  • Harness Dickey IP Law & The Constitution

    August 30, 2019

    Celebrating Labor Day in Patents

    More

  • August 25, 2019

    Trick Question: How Many Utility Patents has the USPTO Issued?

    More

  • August 20, 2019

    Protect Your Intellectual Property or You’ll Lose Your Shirt

    More

  • mage of cracked light bulb to denote IP legal dispute

    August 16, 2019

    Patent Eligibility Can be Determined on the Pleadings, Provided Claim Construction is Not at Issue

    More

  • August 16, 2019

    Liberal Application of Relation Back Doctrine Saved Infringement Claims from Being Time Barred

    More

photo of laboratory and scientist creating biosimilar patents

August 9, 2018

FDA Implements Biosimilar Action Plan to Boost Biosimilar Competition

By: Leanne M. Rakers, Principal

Stay current

  • Subscribe to our Blogs
  • Twitter
  • Facebook
  • LinkedIn
    • Sitemap
    • Privacy Statement
    • Legal Notice

  • © 2019 Harness, Dickey & Pierce, P.L.C. All rights reserved.